Dr. Atul B. Hulwan, Dr. Sujata R. Kanetkar


Today’s transfusion medicine practice aims at  providing the specific component of the blood required;  this process of transfusing only the portion of the blood needed by the patient is called blood component therapy. Transfusion of whole blood has become a rarity now except in certain situations. Blood component therapy has become an integral part of treatment of many diseases in all fields of medicine.1

          In many nations whole blood transfusion is reduced and instead whole blood is separated in to components.  These components are then used separately, as indicated in according to patient’s need.

            It is important to study the pattern of utilization of blood and blood components in the hospital. It helps to find out trend of usage which decreased the cost of treatment, reduce wastage of blood components and improves the infrastructure for storage of blood components for future.

Full Text:



Bhattacharya J, Cyriac SL. Blood component therapy. In: Singal RK (ed) Medicine Update, Association of the Physicians of India 2007; 479-484.

Patel P, Patel S, Patel M. Study Of Blood Donors Characteristics At Teaching Hospital, Western India. NJIRM 2015; 6(4) 56- 62.

Reiss R.F. blood donor wellbeing: a primary responsibility of blood collection agencies. Annal of clinical and laboratory science 2011; 41(1):3-7.

Basu D, Kulkarni R. Overview of blood components and their preparation. Indian J Anaesth 2014; 58(5): 529–537.

Gaur D S, Negi G, Chauhan N, Kusum A, Khan S, Pathak V. Utilization of blood and components in a tertiary care hospital. Indian J Hematol Blood Transfusion 2009; 25(3):91–95.

Mitra J, Mitra K, Nandy S, Roy RN, Mandal PK, Biswas R. Utilisation pattern of blood in a teaching hospital of Kolkata. Indian Journal of Public Health 2004; 48 (4): 205-209.

Farr A. D. The first human blood transfusion. Medical History 1980; 24:143-162.

Makroo RN. Preservation and storage of blood. In Compendium of Transfusion Medicine. Practice of safe Blood Transfusion. J Mitra and Co. 2nd ed; 2009:103-120.

A. Verma, Hemlata. Blood component therapy. Indian Journal of Pediatrics 2008; 75: 717-722.

Sharma S, Sharma P, Tyler L. American Family Physician 2011; 83(6): 719-724.

Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, et al. Platelet transfusion for patients with cancer; Clinical practical guidelines of ASCO. J Clin Onco 2001; 19: 1519-38.

Murphy MF, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions: British Journal of Haematology, 2003; 122: 10-23.

Poterjoy BS, Josephson CD. Platelets, frozen plasma, and cryoprecipi¬tate: what is the clinical evidence for their use in the neonatal intensive care unit? Semin Perinatol. 2009; 33(1): 66-74.

Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowl¬edge. Transfus Med Rev. 2009; 23(3): 177-188.


  • There are currently no refbacks.